CATALYST PHARMACEUTICALS, INC. Quarterly Debt-to-equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Catalyst Pharmaceuticals, Inc. quarterly Debt-to-equity history and growth rate from Q1 2012 to Q3 2024.
  • Catalyst Pharmaceuticals, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 17 %, a 18.3% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 17 -3.81 -18.3% Sep 30, 2024
Q2 2024 17.3 -4.62 -21.1% Jun 30, 2024
Q1 2024 18 -2.81 -13.5% Mar 31, 2024
Q4 2023 20 +1.46 +7.88% Dec 31, 2023
Q3 2023 20.8 +5.1 +32.6% Sep 30, 2023
Q2 2023 21.9 +9.4 +75.1% Jun 30, 2023
Q1 2023 20.8 +8.21 +65.3% Mar 31, 2023
Q4 2022 18.5 +6.34 +52% Dec 31, 2022
Q3 2022 15.7 +3.97 +33.9% Sep 30, 2022
Q2 2022 12.5 +1.03 +8.96% Jun 30, 2022
Q1 2022 12.6 -0.37 -2.86% Mar 31, 2022
Q4 2021 12.2 -2.59 -17.5% Dec 31, 2021
Q3 2021 11.7 -6.18 -34.6% Sep 30, 2021
Q2 2021 11.5 -10.3 -47.1% Jun 30, 2021
Q1 2021 13 -10.4 -44.5% Mar 31, 2021
Q4 2020 14.8 -9.61 -39.4% Dec 31, 2020
Q3 2020 17.9 -4 -18.3% Sep 30, 2020
Q2 2020 21.8 +5.11 +30.7% Jun 30, 2020
Q1 2020 23.3 +12.2 +109% Mar 31, 2020
Q4 2019 24.4 +17 +230% Dec 31, 2019
Q3 2019 21.9 +17 +352% Sep 30, 2019
Q2 2019 16.6 +11.5 +222% Jun 30, 2019
Q1 2019 11.2 +5.66 +103% Mar 31, 2019
Q4 2018 7.4 +0.83 +12.6% Dec 31, 2018
Q3 2018 4.84 -2.23 -31.5% Sep 30, 2018
Q2 2018 5.17 -1.06 -17% Jun 30, 2018
Q1 2018 5.48 -0.64 -10.4% Mar 31, 2018
Q4 2017 6.57 +0.67 +11.4% Dec 31, 2017
Q3 2017 7.07 +0.53 +8.1% Sep 30, 2017
Q2 2017 6.23 -0.48 -7.16% Jun 30, 2017
Q1 2017 6.13 -1.38 -18.4% Mar 31, 2017
Q4 2016 5.89 -3.68 -38.4% Dec 31, 2016
Q3 2016 6.55 -5.68 -46.5% Sep 30, 2016
Q2 2016 6.71 -9.62 -58.9% Jun 30, 2016
Q1 2016 7.5 -10.3 -58% Mar 31, 2016
Q4 2015 9.57 -11.3 -54% Dec 31, 2015
Q3 2015 12.2 -7.06 -36.6% Sep 30, 2015
Q2 2015 16.3 -3.11 -16% Jun 30, 2015
Q1 2015 17.8 -7.3 -29% Mar 31, 2015
Q4 2014 20.8 -1.51 -6.76% Dec 31, 2014
Q3 2014 19.3 -2.55 -11.7% Sep 30, 2014
Q2 2014 19.4 -0.08 -0.41% Jun 30, 2014
Q1 2014 25.1 +7.33 +41.2% Mar 31, 2014
Q4 2013 22.3 -3.14 -12.3% Dec 31, 2013
Q3 2013 21.8 -17.5 -44.5% Sep 30, 2013
Q2 2013 19.5 -19.1 -49.5% Jun 30, 2013
Q1 2013 17.8 -20.3 -53.3% Mar 31, 2013
Q4 2012 25.5 Dec 31, 2012
Q3 2012 39.3 Sep 30, 2012
Q2 2012 38.6 Jun 30, 2012
Q1 2012 38.2 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.